Biobank of stem cells and biomarkers for cardiovascular disease

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This project aims to create a clinical database and biobank of induced pluripotent stem cells (iPSCs) derived from the blood of participants with cardiovascular diseases. It will recruit individuals from diverse racial and ethnic backgrounds, ensuring equal representation of both sexes. The study will analyze blood samples for protein biomarkers and genetic factors associated with cardiovascular disease, facilitating a deeper understanding of the disease mechanisms. The resulting iPSC biobank and clinical data will serve as valuable resources for future cardiovascular research.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Adult (18 to 80 years of age)
* Cardiovascular Disease (CVD)
* Cerebrovascular Disease (CBD)
* Peripheral Vascular Disease (PVD)
* Inherited Arrhythmias
* Cardiomyopathies
* Congenital Heart Disease (CHD)
* Aortopathy
* Hypertension
* Cardiometabolic Disease (CMD)

Exclusion Criteria:

* Younger than 18 years of age.
* Patients not able to provide consent.

Where it's running

• London Regional Health Science Centre
  London, Ontario, Canada Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Longitudinal Assessment of Cardiac MRI Microstructure in Patients and Healthy People

  This study tests advanced, non-contrast and extended clinical cardiac MRI techniques to see how heart tissue features differ between people with heart disease and healthy individuals.

  Recruiting The Cleveland Clinic · Cleveland, Ohio · NCT07081711

• Imaging metabolic processes in the body using Carbon-13 pyruvate

  This study is testing a new type of MRI using a special substance to see if it can help us understand how the body processes energy in people with heart problems and healthy volunteers without using harmful radiation.

  Recruiting Phase 2 National Heart Centre Singapore · Singapore · NCT06645691

• Cardiohelp ECMO support for children with severe cardiac failure

  This study will test the Cardiohelp VA-ECMO system for up to 30 days and try heparin versus bivalirudin as anticoagulants in children (0–16 years) with severe heart failure who need VA-ECMO.

  Recruiting at 5 sites Phase 2 Stanford University · Palo Alto, California and 4 other locations · NCT06080074

• Evaluating a non-invasive method for cardiac resynchronization therapy

  This study tests a new non-invasive device to see how well cardiac resynchronization therapy works for people with heart failure and left bundle branch block during their treatment.

  Recruiting Oslo University Hospital · Oslo · NCT05868616

• Development of advanced MRI techniques for heart disease assessment

  This study is testing new MRI techniques to see how heart tissue differs between people with heart disease and healthy individuals to improve heart assessments.

  Recruiting The Cleveland Clinic · Cleveland, Ohio · NCT05654272

• Registry for adults with congenital heart disease and heart transplantation

  This study is collecting information about adults with congenital heart disease who may need a heart transplant to better understand their experiences and outcomes.

  Recruiting Universitätsklinikum Hamburg-Eppendorf · Hamburg, Free and Hanseatic City of Hamburg · NCT04848844

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.